Review of the article by M. Stenger “Decreasing but still elevated risk for subsequent neoplasms in survivors of childhood cancers”

1. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R. (eds.). NIH Pub. No. 99-4649. Bethesda, MD, 1999.

2. Mertens A.C., Liu Q., Neglia J.P. et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2008;100(19):1368–79. doi: 10.1093/jnci/ djn310.

3. Turcotte L.M., Liu Q., Yasui Y. et al. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970–2015. JAMA 2017;317(8):814–24. doi: 10.1001/ jama.2017.0693.

4. De Bruin M.L., Sparidans J., van’t Veer M.B. et al. Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27(26):4239–46. doi: 10.1200/ JCO.2008.19.9174.

5. Olch A.J. Pediatric Radiotherapy. Planning and Treatment. CRC Press, 2013. P. 24.

6. Huq M.S., Das I.J., Steinberg T., Galvin J.M. A dosimetric comparison of various multileaf collimators. Phys Med Biol 2002;47(12):N159–70.PMID: 12118609.

7. Cui J., Liu C., Meng L., Benedict S. SU-E-T-128: A Comprehensive Dosimetric Characterization of the New 160 Leaf Elekta Agility Collimator System. Medical Physics 2013;40(6):233. doi: 10.1118/1.4814563.

8. Karlsson P., Holmberg E., Lundell M. et al. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998;150(3):357–64. PMID: 9728664.

9. Nguyen F., Rubino C., Guerin S. et al. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 2008;70(3):908–15. doi: 10.1016/j. ijrobp.2007.10.034.

10. Tukenova M., Guibout C., Hawkins M. et al. Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood. Int J Radiat Oncol Biol Phys 2011;80(2):339–46. doi: 10.1016/j. ijrobp.2010.02.004.

11. D’Souza W.D., Rosen I.I. Nontumor integral dose variation in conventional radiotherapy treatment planning. Med Phys 2003;30(8):2065–71. doi: 10.1118/1.1591991.

12. Hermanto U., Frija E.K., Lii M.J. et al. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 2007;67(4):1135–44. doi: 10.1016/j. ijrobp.2006.10.032.

13. Aoyama H., Westerly D.C., Mackie T.R. et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 2006;64(3):962–7. doi: 10.1016/j. ijrobp.2005.11.005.

14. Chung C.S., Yock T.I., Nelson K. et al. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 2013;87(1):46–52. doi: 10.1016/j. ijrobp.2013.04.030.